Understanding PCOS and PCOD
Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD) are often confused due to overlapping symptoms. PCOS is a metabolic and endocrine disorder with long-term risks, including type 2 diabetes, cardiovascular disease, and infertility, whereas PCOD is generally linked to lifestyle factors like poor diet, obesity, and stress. While PCOD can often be managed through lifestyle changes, PCOS has systemic effects and requires comprehensive care.
Prevalence and Impact
Globally, PCOS affects 6–13% of reproductive-age women, with nearly 70% undiagnosed, making it a silent epidemic. Symptoms appear in late teens or early 20s, including irregular periods, acne, obesity, infertility, and emotional distress such as anxiety or depression.
Symptoms and Diagnosis
Common signs include irregular or absent periods, hyperandrogenism (hirsutism, acne, male-pattern baldness), polycystic ovarian morphology, weight gain, and insulin resistance (acanthosis nigricans).
Diagnosis follows the Rotterdam criteria: at least two of three—irregular ovulation, hyperandrogenism, or polycystic ovaries on ultrasound/high AMH levels—after ruling out other conditions like hypothyroidism.
Management Strategies
Lifestyle Modifications
First-line treatment emphasizes weight management, even modest (5–10%) loss improves ovulation and metabolic health.
Diet: Limit refined carbs and sugars; prioritize high-fiber foods (vegetables, legumes, whole grains), lean proteins, and healthy fats (olive oil, omega-3s). Low-GI and Mediterranean diets are most effective.
Exercise: Aerobic activity (150–300 min/week), strength training, HIIT, and yoga/Pilates improve insulin sensitivity, regulate hormones, and reduce stress.
Stress & Sleep: Mindfulness, yoga, and 8 hours of sleep improve cortisol regulation, mood, and insulin balance.
Pharmacological Treatments
Medication is tailored to symptoms:
Irregular periods: Oral contraceptives regulate cycles, reduce androgens, and protect against endometrial cancer; progestogen tablets induce periods.
Hyperandrogenism: Oral contraceptives, spironolactone, finasteride, topical eflornithine, and acne treatments (retinoids, benzoyl peroxide, antibiotics).
Insulin resistance: Metformin is widely used; other drugs include pioglitazone, liraglutide, semaglutide, and orlistat.
Fertility Management
Options include ovulation induction (letrozole—now preferred over clomiphene, plus metformin), gonadotropins, and IVF. In resistant cases, laparoscopic ovarian drilling (LOD) may be considered.
Long-Term Health Risks
PCOS increases risks of type 2 diabetes, metabolic syndrome, NASH, cardiovascular disease, endometrial cancer, pregnancy complications, and mental health disorders. Regular screenings for blood pressure, glucose, lipids, and mental health are essential.
Multidisciplinary Care
Optimal management requires collaboration among gynecologists, endocrinologists, dermatologists, dietitians, and psychologists to ensure holistic care.
Future Directions
Emerging research explores GnRH antagonists, melatonin, PI3K pathway modulation, statins, gut microbiota interventions (probiotics, FMT), acupuncture, and AI-driven personalized treatments. These may shift care toward precision and preventative medicine.
Conclusion
PCOS is a lifelong, systemic condition requiring lifestyle changes, symptom-specific medications, fertility support, and proactive health monitoring. With multidisciplinary care and emerging therapies, management is moving toward more personalized and effective approaches.